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a b s t r a c t
An infectious clone of a highly pathogenic PRRSV strain from Vietnam (rSRV07) was prepared and was
demonstrated to contain multiple amino acid differences throughout the genome when compared to
Chinese highly pathogenic PRRSV strain rJXwn06. Virus rescued from the rSRV07 infectious clone was
compared to rJXwn06 and US Type 2 prototype strain VR-2332 to examine the effects of virus genotype
and phenotype on in vitro growth, and virus challenge dose on in vivo pathogenicity and host response.
After swine inoculation at high- and low-doses of virus, rSRV07 was shown to replicate to an
approximately 10-fold lower level in serum than rJXwn06, produced lower body temperatures than
rJXwn06 and resulted in decreased mortality. Furthermore, a 9-plex cytokine panel revealed that the
cytokine responses varied between different strains of PRRSV, as well as between tissues examined and
by inoculum dose.
Published by Elsevier Inc.
Introduction
Two broad genotypes have been established for porcine repro-
ductive and respiratory disease virus (PRRSV), a single-stranded
positive-sense RNA virus that is a member of the family Arterivir-
idae. Type 1, represented by the European prototype strain
Lelystad (Meulenberg et al., 1993; Wensvoort et al., 1992), and
Type 2, represented by the North American prototype strain VR-
2332 (Benﬁeld et al., 1992; Nelsen et al., 1999) possess about 60%
nucleotide identity to each other. However, each genotype consists
of multiple subgenotypes that vary substantially. A new subgeno-
type emerged in 2006 in Chinese provinces where herds experi-
enced a high fever disease with severe morbidity and mortality
rates (Li et al., 2007; Tian et al., 2007; Tong et al., 2007; Wu et al.,
2009; Zhou et al., 2008). Now known as highly pathogenic PRRSV
(HP-PRRSV), the viral genomes contain unique discontinuous
deletions compared to prototype strain VR-2332 and constitute a
new lineage of Type 2 PRRSV (An et al., 2010), and the
HP-PRRSV viruses have now spread throughout many Asian
countries (An et al., 2011; Metwally et al., 2010; Ni et al., 2012).
In addition, virus rescued from HP-PRRSV infectious clone
rJXwn06 was recently used to recapitulate porcine high fever
disease in 10 week-old United States high health swine (Guo et al.,
2013), causing acute weight loss, bacterial sepsis and severe
histopathological lung lesions and conﬁrming the pathogenicity
of this new lineage (Lv et al., 2008; Zhou et al., 2009). However,
direct comparison of disease pathogenicity between different
strains of HP-PRRSV (Li et al., 2010; Yu et al., 2012), and examina-
tion of the innate and adaptive immune responses to such
pathogenic strains has been limited (Guo et al., 2013; Liu et al.,
2010; Shang et al., 2013; Wang et al., 2011). Furthermore, assess-
ment of the disease severity of rJXwn06 on younger animals and
an understanding of the consequences of low and high
dose inoculation of HP-PRRSV in U.S. swine was needed (Guo
et al., 2013).
For this study, an infectious clone was generated from viral
RNA of a Vietnamese HP-PRRSV isolate and was used to
rescue infectious virus (rSRV07). The replication of rSRV07
was compared to Chinese HP-PRRSV rJXwn06 and US Type
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2 prototype VR-2332, both in vitro and in vivo, to examine the
effect of virus phenotype and genotype, in addition to the
importance of challenge dose and viral strain, on swine patho-
genicity and host response. We found that the two HP-PRRSV
strains could be phenotypically and genotypically distinguished
from each other as well as from strain VR-2332, both in MARC-145
cells and in 4-week old swine. In addition, the results from a 9-
plex cytokine panel showed that the individual cytokine responses
varied between the different strains of PRRSV and by the dose of
virus given.
Results
Genome comparison
From puriﬁed RNA of HP-PRRSV sampled from a herd in
the Socialist Republic of Vietnam and isolated by the Animal and
Plant Health Inspection Service of the United States Department of
Agriculture, the full-length nucleotide sequence for SRV07
(GenBank ID JX512910) was generated based on primers derived
from other HP-PRRSV strains (Table 1). A minimum three-fold
Table 1
Primers used in the generation of pSRV07. Inserted unique enzyme sites are shown in bold. The SP6 promoter sequence is underlined.
Name Segment Nucleotides Sequence
SRV-Leader 1 1–25 5′-AGATGGCCGGCCATTTAGGTGACACTATAGAT
GACGTATAGGTGTTGGCTCTATG-3′
3557R 3,534–3,557 5′-TCAAGCAGCTCGTCAGTGTCTCCT-3′
F2508 2 2,508–2,532 5′-GATGGAGGAGGATCTGCTAAAACTA-3′
5096R 4,993–4,970 5′-TCAAGCAGCTCGTCAGTGTCTCCT-3′
F4800 3 4,800–4,821 5′-ACTAAAGATCAGGCAAATTTCC-3′
7676R 7,654–7,676 5′-TATTTTTACCGCTGTCTCAGTAA-3′
F7514 4 7,514–7,533 5′-ACGTCGACGGCGAACTGACT-3′
12420R 12,397–12,420 5′-AGCCACCACATCCAAACCACTAAT-3′
F11805 5 11,805–11,828 5′-TTTGAATCGGATACAGCGTATCTG-3′
SRV-3′endR 15,312–15,320 5′-GTCTTTAATTAACTAGTTTTTTTTTTTTTTT
TTTTTTTTTTTTTTTAATTACGGC-3′
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Fig. 1. (A) PRRSV genome schematic. Open reading frame (ORF) 1ab, three fourths of the genome, encodes the replicase polyprotein (black arrow) that is cleaved
cotranslationally into discrete peptides (white arrows) by virally encoded proteases. The remaining black arrows deﬁne the smaller structural ORFs. The 5′ and 3′ UTRs are
shaded in grey. Below the schematic, the genomes of HP-PRRSV strains JXwn06, SRV07 and 07QN are depicted, with differences from the consensus shown as black
perpendicular lines. (B) Multistep growth curve analyses. HP-PRRSV strains rSRV07 and rJXwn06 were compared to wt strain MN184 and US Type 2 prototype VR-2332.
Results were plotted as PFU/ml with the error bars portraying the standard deviation. (C) Plaque morphology of the Type 2 strains. D. Northern blot analysis using a labeled
probe complementary to the 5′-leader sequence.
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genome coverage was obtained. The rSRV07 genome possessed
99.4% pairwise identity to the genome of rJXwn06, rJXwn06
showed 99.1% identity to the only other Vietnamese genome
available (07QN), and the two Vietnamese genomes share 99.2%
identity. Although all three strains share above 99% identity, each
strain is unique when compared to each other (Fig. 1A). Table 2
details the nucleotide and amino acid similarities between rSRV07
and rJXwn06 when broken down into discrete genomic regions.
The 3′ ends of these two HP-PRRSV genomes, including ORF7 and
the 3′UTR, possess the most divergence. In addition, the GP5
protein for rSRV07 was predicted to have one less N-glycan residue
(N X  S/T) than the Chinese HP-PRRSV strain, but is otherwise
identical to the respective protein of rJXwn07 (data not shown).
Comparison to other U.S. index isolates reveal they have approxi-
mately 89% pairwise identity to VR-2332, and are 91.4 and 82.4%
identical to JA142 and MN184, respectively.
In cellulo phenotype comparison of rJXwn06 and rSRV07
An infectious clone (pSRV07) was also generated. The full-
length transcript was prepared and used to transfect MARC-145
cells. Virus (recombinant SRV07; rSRV07) was rescued, harvested
at 5 days post transfection, and ampliﬁed by two additional
passages on MARC-145 cells.
To compare the kinetics of rSRV07 to rJXwn06, MN184 and VR-
2332, simultaneous multi-step growth curve analyses were completed
(Fig. 1B). rSRV07 replicated with similar kinetics as VR-2332
(5.4106 PFU/ml), approximately one half log lower at peak titer
than rJXwn06 (1.7107 PFU/ml). Until 36 h post infection (hpi),
MN184 replicated at about one half log lower kinetics (1.7106
PFU/ml) than rSRV07 and VR-2332, but eventually reached the same
titer as rSRV07. We also examined plaque morphologies produced by
these strains and found that rSRV07 produced slightly smaller plaques
than rJXwn06, about the same size as MN184 plaques, but larger than
those of VR-2332 (Fig. 1C).
Next, we examined the display of genomic and subgenomic
mRNAs (sgmRNA) in infected MARC-145 cells. Intracellular RNA of
four Type 2 PRRSV strains was puriﬁed, the RNAs electrophoresed
and then transferred to a membrane and probed with an oligomer
complementary to the 5′ leader sequence (Fig. 1D). As published
previously, VR-2332 RNA transcripts include two species for ORF7
message, 7-1 and 7-2, and several other weaker bands not aligning
Table 2
Nucleotide and amino acid identities between HP-PRRSV strains rJXwn06 and rSRV07. Speciﬁc amino acid changes are denoted by grey (conservative), underlined
(semiconservative), or boldface text (nonconservative).
Region Nucleotide length % Nucleotide identity % Amino acid identity Amino acid change:
rJXwn06[AA]rSRV07
5′UTR 190 98.9
ORF1ab
nsp1α 540 99.8 100.0
nsp1β 609 99.0 98.5 D9G|V34I|A139T
nsp2 3498 99.3 98.8 T8P|V15M|T161S|Q219H|R383G
nsp3 690 99.3 100.0
nsp4 612 99.5 99.0 Q33K|R62K
nsp5 510 99.6 99.4 V118M
nsp6 48 100 100.0
nsp7α 447 99.6 100.0
nsp7β 330 99.1 97.3 N13S|T90S|G105R
nsp8 138 99.3 100.0
nsp9 2055 99.5 99.8 T588I
nsp10 1323 99.8 100.0
nsp11 669 99.1 99.1 V29A|V97M
nsp12 462 99.1 99.4 T5S
ORF2a 771 99.5 99.6 S32L
ORF2b 222 99.5 99.6 S32L
ORF3 765 99.3 99.6 H223L
ORF4 537 98.9 99.8 S4P|P59S
ORF5a 46 99.3 97.8 L40P
ORF5 603 99.3 99.5 S37P
ORF6 525 99.6 100.0
ORF7 372 97.8 96.0 G51E|P66H|L77S|P101T|P118T
3′UTR 151 96.7
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Fig. 2. Average daily weight gain during each week of study. Number of surviving
pigs at low- and high-dose Asian HP-PRRSV challenge is indicated at the bottom of
each bar if animals died during the timeframe of interest. Signiﬁcance between
group pairing are indicated by the P value above the respective bracket; n.s.¼not
signiﬁcant.
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with the standard sgmRNA2-6, termed heteroclites (Latin for
“deviating from common forms or rules) (Yuan et al., 2000), and
MN184 RNA transcript display is relatively devoid of heteroclites
and sgmRNA7-2 (Wang et al., 2008). The two HP-PRRSV RNAs are
expressed differently from both of these phenotypes and from
each other. rSRV transcripts show an increased amount of genomic
RNA, possess ample sgmRNA7-2 but lack most heteroclite species,
while rJXwn06 RNAs show sgmRNA7-2 and evidence of hetero-
clites. Lastly, the abundance ratios of genomic to sgmRNAs appear
unique for each strain of virus.
In vivo study
The two HP-PRRSV strains were then compared, along with US
prototype strain VR-2332, for pathogenicity in 4 week-old swine
as opposed to 10-week old swine published previously (Guo et al.,
2013). Two PRRSV doses were used, low (2103 TCID50) and high
(2106 TCID50), to assess whether or not the clinical disease
manifestations would differ depending on the initial inoculum of
virus, as was shown previously for U.S. strain SDSU73 (Loving
et al., 2008).
Average daily weight gain (ADWG) was calculated for each
week of study (Fig. 2). By the end of the ﬁrst week, rJXwn06
inoculated piglets were losing weight with one death, whereas the
rSRV07 and VR-2332 inoculated groups showed low to modest
weight gain, depending on viral challenge dose. All rJXwn06
challenge piglets died by the end of the study, and were not
weighed at necropsy, whereas both rSRV07 and VR-2332 groups
lost weight during the second week. Control pigs gained weight
over the duration of the study.
Control pigs showed normal behavior throughout the experiment.
In contrast, virus-challenged pigs exhibited clinical disease with
variable severity depending on challenge virus and to a lesser extent,
dose. In the low and high dose rJXwn06-challenged groups, most pigs
developed fever within 2 days post-challenge (dpc), and in all by
3 dpc, was signiﬁcantly elevated until death for each pig (Fig. 3A).
Concurrent with the onset of pyrexia, pigs became listless and
anorexic leading to cachexia reﬂected by weight loss. Acute respira-
tory distress, characterized by dyspnea, tachypnea and coughing was
common in low- and high-dose rJXwn06 infected swine beginning
1–3 dpc. Intermittent erythema of the skin was present in most of the
pigs infected with rJXwn06 beginning 2–3 dpc, and several developed
cutaneous hemorrhages and cyanotic extremities (blue ears), as seen
previously (Guo et al., 2013). Conjunctivitis, rhinitis, diarrhea, and
vomiting were seen in some of the pigs. At 4 dpc, one pig in the low-
dose challenge group was found dead; it had died between the late
afternoon and evening observation time points. On the morning of
5 dpc, a pig in the low-dose rJXwn06 group was euthanized for
humane purposes and in the evening the ﬁrst pig in the high-dose
group was euthanized. All remaining pigs had either died or were
euthanized by 11 or 9 dpc for the rJXwn06 low and high challenge
groups, respectively (Fig. 4). Compared to the rJXwn06 pigs, the onset
of clinical disease (respiratory disease, weight loss) in both the low-
and high-dose rSRV07 challenge groups was slower, less in
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Fig. 3. Daily rectal temperatures of each PRRSV strain at low and high dose in
comparison to the control group. (A) rJXwn06. (B) rSRV07. (C) VR-2332.
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magnitude, and less lethal (Figs. 2 and 4). The pigs infected with the
high-dose of rSRV07 had elevated rectal temperatures after day 2
(avg. 40.4 1C) similar to those infected with a high dose of rJXwn06
(avg. 40.6 1C) (Fig. 3A and B), but the response was delayed by 1 day,
and low-dose rSRV07 challenged swine had less fever (avg. 39.8 1C),
due in part to the delay in virus replication (see below). Towards the
end of the study, the rSRV07-infected swine appeared to become
more affected, and 3 pigs in the high challenge group died (Fig. 4;
days 12 and 13; 2 were euthanized and 1 died). Animals in the low
dose rJXwn06 challenged group tended to display less fever earlier in
the experiment, but on 7 dpc reached the same elevated temperature
of the high-dose rJXwn06 group. VR-2332 challenged pigs were
mildly affected during the course of the study with slight increases
in rectal temperature, respiration rates and weight loss beginning
about 7 dpc (Fig. 2 and Fig. 3C). No swine infected with strain VR-
2332 succumbed (Fig. 4).
Gross pathology
No lesions were observed in control pigs. A range of lesions was
observed in the rJXwn06-challenged 4 week-old swine. Most
consistent was a generalized lymphadenopathy with enlarged
lymph nodes throughout the pig and a severe pneumonia that
generally had a cranioventral distribution consisting of lobular
purple-colored consolidation combined with a diffuse tan-colored
mottling of the lung that involved a majority of the lung, in
accordance with our previous Chinese HP-PRRSV study on 10
week-old swine (Guo et al., 2013). Less frequently observed lesions
were thymic atrophy, pericardial and peritoneal effusions, ﬁbrinous
pleuritis, and petechial hemorrhages on the surface of the heart and/
or kidney. Comparable lesions were found in the 3 pigs from the high-
dose rSRV07 challenge group that died before 14 dpc. In the remaining
rSRV07 high and low dose challenge pigs similar, but less intense,
lesions were found. Animals in the VR-2332 challenge group had mild
to moderate pneumonia with tan-colored diffuse surface lesions. In
addition, a generalized lymphadenopathy similar to the other two
virus challenge groups was seen.
PRRSV antibody detection
To monitor the time of seroconversion to PRRSV nucleocapsid
protein, serum samples from study days 0 and 14 were analyzed by
HerdChek PRRS 3XR ELISA (data not shown). All PRRSV-infected
swine had seroconverted by day 14, except 10 of the 11 animals
challenged with low-dose rSRV07, which suggested the low dose
rSRV07 inoculum did not replicate efﬁciently until later in the study.
Virus isolation
Serum and bronchoalveolar lavage ﬂuid (BALF) samples were
examined by virus isolation (VI) followed by titration (Fig. 5). For
all three PRRSV strains, the dose given to animals resulted in very
little if any difference in viral titer for the swine that were viremic
(Fig. 5A). Differences were seen between the separate strains,
however. Both low- and high-dose rJXwn06 resulted in the highest
peak titer (avg. 106.8 at 7 dpc), followed by rSRV07 (avg. 105.4 at
11 dpc) and then VR-2332 (avg. 104.1 at 7 dpc). As noted above, the
low dose rSRV07 did not initially replicate well in all pigs, and the
number of pigs testing VI positive is referred to by the alphabetical
characters in Fig. 5A. Analysis of BALF ﬂuid at necropsy (Fig. 5B)
revealed signiﬁcantly different VI titers between high and low
doses of rSRV07 (Po0.001) that could be related to the low dose
viral replication delay, but not between the different doses of
rJXwn06 or VR-2332. It was interesting to note that the viral titers
in the BALF were greatest for the high dose rSRV07 group, even
though the mean serum VI titer for this group was less than
rJXwn06-infected animal mean.
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Fig. 5. (A) Virus isolation from serum samples. Mean log10 virus titer for positive swine. Alphabetical characters indicate the number of swine in low-dose SRV07 that tested
positive on days 4 (a¼1), 7 (b¼2), and 11 (c¼5). Number of surviving pigs at low- and high-dose (boldface) Asian HP-PRRSV challenge is indicated to the right of each
respective time point if animals died during the study. (B) Virus isolation from BALF reﬂect when animals were necropsied. Number of pigs (numerator)/number of positive
isolations (denominator) is enumerated when samples from less than all 11 animals were obtained. Signiﬁcance between group pairings are indicated by the P value above
the respective bracket; n.s.¼not signiﬁcant.
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Bacterial isolation
Secondary bacterial infections were common sequelae with the
Asian strains of PRRSV, whereas no secondary bacterial infections
were detected in the non-infected controls or the VR-2332
inoculated swine. As far as systemic bacterial isolations, Strepto-
coccus suis was isolated from the brain of 2 of the pigs that were
inoculated with the low dose of rJXwn06 and from the brain and
heart of 1 pig inoculated with the high dose of rSRV07. Bacteria
were isolated from the BALF of 10 of the 11 pigs inoculated with
the low dose of rJXwn06, from 9 of the 11 pigs inoculated with the
high dose of rJXwn06 and from 10 of the 11 pigs inoculated with
both the low and high doses of rSRV07. S. suis was the most
common bacteria isolated from the BALF, from 28 of the pigs, the
next most common was Haemophilus parasuis from 13 pigs.
Escherichia coli, Pasteurella multocida, Arcanobacterium pyogenes,
Staphylococcus and Klebsiella spp. were the other bacteria isolated
from 1 to 3 HP-PRRSV pigs each. Two or more bacteria were
isolated from the BALF of 11 of the pigs, speciﬁed in Table 3.
Cytokine analysis
Innate immunity associated cytokines
Swine inoculated with a high dose of rJXwn06 HP-PRRSV had
signiﬁcantly elevated serum TNFα levels detectable 7 dpc (versus
controls) that reached a zenith at 11 dpc (versus all treatment
groups), after which no animals survived (Fig. 6A). In comparison
with high dose rJXwn06 infection, those inoculated with the other
PRRSV strains had lower yet signiﬁcantly elevated serum TNFα
levels at 7 dpc (VR-2332 dose versus controls) and at 11 and
14 dpc (rSRV07 low dose versus controls). However, only one
animal given a low dose of rSRV07 had extraordinarily high levels
of all serum cytokines at 11 dpc, indicated by the large error bar in
each cytokine panel. Likewise, swine inoculated with high dose
rJXwn06 HP-PRRSV had signiﬁcantly elevated serum IL-1β levels
detectable 7 dpc (versus controls) that reached a maximum at
11 dpc (versus all treatment groups), after which no animals
survived. Pigs inoculated with high dose VR-2332 had a more
modest peak level of IL-1β at 7 dpc while those inoculated with
high and low dose rSRV07 had a somewhat delayed (peaking at
11 dpc) yet signiﬁcant elevation of IL-1β

. No statistically
signiﬁcant alterations were seen in serum IL-6 or IL-8 levels for
swine inoculated with VR-2332, rSRV07 or rJXwn06 HP-PRRSV.
Adaptive immunity associated cytokines
Pigs inoculated with high dose rJXwn06 HP-PRRSV had statistically
signiﬁcant elevations in serum IFN-γ levels at 7 and 11 dpc. In addition,
pigs inoculated with VR-2332 (high dose) had a signiﬁcant elevation
in serum IFN-γ levels at 7 dpc while pigs inoculated with rSRV07 (both
doses) had signiﬁcant elevations in serum IFN-γ levels at 11 and
14 dpc (Fig. 6B). Swine inoculated with rSRV07 or rJXwn06 HP-PRRSV
had statistically signiﬁcant alterations in serum IL-2 levels with high
and low dose rJXwn06 inoculated pigs rising sooner (7 dpc) and
peaking higher than rSRV07 (low dose) inoculated pigs at 11 dpc.
Swine inoculated with high dose rJXwn06 HP-PRRSV had statistically
signiﬁcant elevations in serum IL-10 levels at 7 and 11 dpc, whereas
those given low dose rJXwn06 had elevated serum IL-10 only at 7 dpc.
In addition, pigs inoculated with rSRV07 (low dose) had a signiﬁcant
elevation in serum IL-10 at 11 dpc. Pigs inoculated with high dose
rJXwn06 HP-PRRSV had statistically signiﬁcant elevations in serum IL-
12p70 levels at 7 and 11 dpc while low dose rJXwn06 inoculated
swine showed elevated IL-12p70 only at 7 dpc. In addition, pigs
inoculated with rSRV07 (low dose) had a signiﬁcant elevation in
serum IL-12p70 at 11 dpc. There were no statistically signiﬁcant
alterations in serum IL-4 levels seen.
Cytokine levels in BALF
Similarly, when compared to sham inoculated controls, BALF of
swine inoculated with rJXwn06 (both doses) had signiﬁcantly elevated
levels of 3 out of 4 innate immunity cytokines measured (TNFα, IL-1β
and IL-8; Fig. 7A) and elevated levels for all 5 cytokines measured
associated with adaptive immunity (IFN-γ, IL-2, IL-4, IL-10, IL-12;
Fig. 7B). Swine inoculated with a high dose of rSRV07 had lower but
signiﬁcantly elevated BALF cytokine levels for 3 out of 4 innate
immunity cytokines measured (TNFα, IL-1β and IL-8) and elevated
levels for 4 of 5 cytokines measured associated with adaptive
immunity (IFN-γ, IL-2, IL-4, IL-10). Those animals given a low dose of
rSRV07 had 2 of 4 innate immunity cytokines elevated (IL-1β and IL-8)
and only 1 of 5 adaptive cytokines elevated (IL-10). In contrast, swine
inoculated with VR-2332 had signiﬁcantly elevated (albeit lower) BALF
cytokine levels for only 2 out of 4 innate immunity cytokines
measured (IL-1β and IL-8) and elevated levels for 4 of 5 cytokines
Table 3
Individual bacterial isolations from bronchoalveolar lavage ﬂuid (BALF) samples.
# Isolations # Pigs Strep Hps E. coli Pm A. pyo Staph Kleb
Control 0/11        
VR-2332 (Low) 0/11        
VR-2332 (High) 0/11        
rSRV07 (Low) 10/11 3 þ      
1 þ   þ   
4  þ     
1   þ    
1    þ þ  
rSRV07 (High) 10/11 3 þ      
2 þ þ     
3  þ     
2   þ    
rJXwn06 (Low) 10/11 8 þ      
1 þ þ     
1 þ      þ
rJXwn06 (High) 9/11 4 þ -     
3 þ þ     
2 þ þ    þ 
Strep¼Streptococcus suis; Hps¼Haemophilus parasuis; E. coli¼Escherichia coli; Pm¼Pasteurella multocida; A. pyo¼Arcanobacterium pyogenes; Staph¼Staphylococcus spp.;
Kleb¼Klebsiella spp.
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measured associated with adaptive immunity (IL-2, IL-4, IL-10 and
IFN-γ).
Cytokine levels in TBLN homogenates
Compared to controls, swine inoculated with low dose rSRV07 had
signiﬁcantly elevated levels in 3 of 4 innate immunity cytokines
measured (TNFα, IL-1β, IL-8; Fig. 8A) and elevated levels for only 1 of
5 adaptive immunity cytokines (IFNγ; Fig. 8B). Interestingly, those
animals given a high dose of rSRV07 showed elevated levels versus
control animals only for IL-8 (innate) and TNFα (adaptive). Statistically
signiﬁcant elevations of cytokines were not seen for both doses of VR-
2332 infected animals, when compared to control animals. No TBLN
were collected from swine inoculated with rJXwn06 due to unanti-
cipated times of animal death.
Discussion
The purpose of this study was to examine the distinctive patho-
physiological effects of low and high dose intranasal inoculation of
two different HP-PRRSV strains in tandem with well-documented
North American Type 2 prototype strain VR-2332. Four-week old
swine were chosen for the clinical investigation. Our previous report
was limited to a high input dose due to the uncertain outcome of
infection of 10-week old United States swine (Guo et al., 2013). The
development of an infectious clone for the Vietnamese isolate,
described in this study (rSRV07), allowed investigation into the
pathogenic effects of both input dose and highly pathogenic viral
strain. Only one other full-length Vietnamese isolate sequence (07QN,
GenBank FJ394029) has been shown to be similar to the highly
pathogenic isolates of China, but no comparative clinical studies using
this isolate have been reported (Feng et al., 2008). The genome of
07QN is 99.2% identical in nucleotide sequence to rSRV07 but was
shown to contain many amino acid changes (Fig. 1A and data not
shown). rSRV07 was shown to harbor 31 amino acid changes when
compared to highly pathogenic strain from rJXwn06 and to replicate
on MARC-145 cells about 1 log lower at peak titer than the Chinese
strain. Thus, we were able to differentiate the two HP-PRRSV strains
genotypically, and showed that their phenotypes could also be
distinguished.
Our clinical results clearly demonstrated that the highly patho-
genic viruses were more virulent than VR-2332 but they also
varied from each other in several ways. rJXwn06 caused rapid and
severe weight loss leading to the death of all 4-week old swine
within 12 days, while rSRV07 infected animals did not exhibit
weight loss until the second week of infection and only three
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Fig. 6. (A) Innate cytokine (TNFα, IL-1β) protein levels in serum samples at speciﬁed days post exposure and (B) adaptive cytokine (IL-2, IL-10, IL-12) protein levels in serum
samples at speciﬁed days post exposure.
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animals succumbed by study end. In addition, animals infected
with rJXwn06 had body temperatures averaging 40.6 1C, whereas
those infected with the high dose of rSRV07 had temperatures
about 40.4 1C and no animal reached a temperature of 41 1C.
Consistent with our in cellulo ﬁndings, the three virus strains
replicated in swine differently as well, with rJXwn06 replicating to
Fig. 7. (A) Innate cytokine (TNFα, IL-1β, IL-8) protein levels in bronchoalveolar lavage (BALF) at necropsy and (B) adaptive cytokine (IL-2, IL-4, IL-10, IL-12) protein levels in
BALF at necropsy. Signiﬁcance between group pairings are indicated by the P value above the respective bracket; n.s.¼not signiﬁcant.
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very high titers (TCID50/ml of 7 logs) in serum while rSRV07
replicated in serum about to about 1 log lower titer. Importantly,
as discussed below, the cytokine responses were qualitatively
similar between the animals infected with rJXwn06 and rSRV07
however, they differed markedly in the cytokine levels reached as
well as the temporal kinetics of the cytokine proﬁle.
A challenge dose effect was also seen. While the viral titers at
day 4 did not differ substantially between the high and low dose
Fig. 8. (A) Innate cytokine (TNFα, IL-1β, IL-8) protein levels in tracheobronchial lymph node (TBLN) at necropsy and (B) Adaptive cytokine (, IL-12) protein levels in TBLN at
necropsy. Signiﬁcance between group pairings are indicated by the P value above the respective bracket; n.s.¼not signiﬁcant.
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study groups, the rectal temperatures taken during the course of
the experiment showed that febrile responses were varied. On
average, low-dose rJXwn06 infected animals ﬂuctuated daily
between 39.5 and 40.5 1C before reaching the approximately
41 1C threshold at day 7. The high-dose rJXwn06 infected swine
reached 41 1C by day 5. Conversely, swine infected with the low
dose rSRV07 did not replicate virus well initially and the marked
difference in temperatures between the low and high dose groups
were maintained throughout the experiment.
Overall, our ﬁndings of serum innate cytokine levels in pigs
inoculated with the rJXwn06 HP-PRRSV strain were very consistent
with previous ﬁndings (Guo et al., 2013); any differences were relative
quantitative differences that are to be expected between different
groups of pigs of differing ages in studies conducted at different time
points. As a general statement, the serum cytokine levels detected in
pigs inoculated with the rSRV07 HP-PRRSV strainwere lower than and
often delayed in their elevation in comparison to the cytokine
response to infection with rJXwn06. One pig in the group inoculated
with the low dose rSRV07 HP-PRRSV had extremely high serum
cytokine levels on 11 dpc which resulted in a skewing of the overall
group mean for that dpc above the level for the high dose rSRV07 HP-
PRRSV group mean. We have no explanation for this outlier response
but are conﬁdent in the values obtained for this animal (Fig. 6). In
contrast to our previous ﬁndings where none of the 10 cytokines
measured had signiﬁcant elevations in serum levels detected in pigs
inoculated with the North American prototype strain VR-2332 when
compared with sham inoculated controls, we did detect signiﬁcant
elevation of serum TNFα, IL-1β and IFN-γ levels at selected time points.
The elevations in IFN-γ levels observed in this study are actually
consistent with earlier studies with VR-2332 (Faaberg et al., 2010).
Similar to the innate cytokine results, our ﬁndings for adaptive
cytokines in the serum were virtually identical to what we
reported previously (Guo et al., 2013); quantitative differences
were found that are to be expected between different groups of
pigs of differing ages in studies conducted at different time points.
Compared with sham inoculated controls, swine inoculated with
rSRV07 (some differences by challenge dose) had signiﬁcantly elevated
BALF cytokine levels that were generally intermediate between levels
observed with rJXwn06 and VR-2332 in all innate immunity cytokines
measured (TNFα, IL-1β, IL-6 and IL-8) and elevated levels for 4 of
5 cytokines measured associated with adaptive immunity (IL-2, IL-4,
IL-10 and IFNγ).
Several studies have reported morbidity and mortality associated
with HP-PRRSV infections of pigs with several reporting host cytokine
responses. Although the mechanistic basis for the pathophysiology of
HP-PRRSV infections in pigs is still unfolding, we generally conﬁrmed
our previous ﬁndings of an elevated cytokine syndrome (increased
and sustained serum IFNα, TNFα, IL-1β, IL-2, IL-4, IL-10, IL-12 and IFN-γ
levels) in 10-week old pigs infected with rJXwn06 (Guo et al., 2013).
The cellular origin of these host cytokines during a HP-PRRSV infection
remains to be fully deﬁned. In an attempt to clarify conﬂicting
published reports on the effects of PRRSV on host cytokine responses,
an extensive examination of the in vitro cytokine production proﬁle of
various porcine antigen presenting cells infected with one of 39
different PRRSV isolates found a range of effects based on the viral
strain and the host cell type infected (Gimeno et al., 2011). Although all
39 isolates tested induced high levels of IL-1 and IL-8 in porcine
alveolar macrophage cultures, the PRRSV strains could be differen-
tiated from each other based on the 4 possible phenotypes for their
ability to induce IL-10 and TNFα production. In the study reported
here, all three strains of PRRSV appeared capable of inducing detect-
able levels of TNFα, IL-1β, IFNγ, IL-10 and IL12p70. However, the three
PRRSV strains evaluated here differed in their serum cytokine proﬁles
in terms of cytokine level and kinetics. Similarly, signiﬁcant elevations
in both innate and adaptive immunity associated cytokines were
detected in BALF at necropsy following infection with each strain
studied here, but most dramatically with the Chinese HP-PRRSV
rJXwn06 strain. The variable cytokine levels in BALF could be affected
by differences in disease severity and/or stage of infectionwith a more
slowly replicating virus.
It has been hypothesized that early over-expression and/or pro-
longed high levels of IL-10 might impair an effective immune
clearance as a result of its anti-inﬂammatory activities (Mege et al.,
2006). Others have extended this concept to PRRSV pathogenesis
where sustained elevated levels of IL-10 and IFNγ have been observed
(Borghetti et al., 2011; Johnsen et al., 2002). We noted similar
sustained elevations of IL-10 and IFNγ in pigs infected with HP-
PRRSV strains. In our current study, 4-week old pigs infected with
the Chinese HP-PRRSV rJXwn06 strain clearly failed to mount an
effective host immune response as they succumbed within 11 days or
less following exposure to virus. Another study with a different
Chinese HP-PRRSV (HuN4) strain infecting 8-week old pigs also
observed severe clinical disease and some mortality in association
with increased IL-10 levels that reached a zenith 10 days post exposure
(Wang et al., 2011). These authors also reported vaccination with an
attenuated virus signiﬁcantly ameliorated clinical disease caused by
HP-PRRSV HuN4 and was associated with a reduced serum level of IL-
10 following experimental challenge. The challenge dose in the study
by Wang et al. (2011) was 9.4104 TCID50 and intermediate to the
challenge doses reported here where all pigs died in 12 days or less
following challenge; whereas only 3 of 11 pigs challenged with HP-
PRRSV HuN4 strain died within 12–26 days post-challenge (Wang
et al., 2011).
Polyclonal B-cell activation can result in IL-10 producing B-cells
(Parcina et al., 2013) and such immune dysregulation might
explain the elevated serum IL-10 levels observed in several studies
with PRRSV. B-cell hyperplasia or polyclonal activation has been
reported as a component of PRRSV pathogenesis (Butler et al.,
2007, 2008;Lamontagne et al., 2001; Lemke et al., 2004; Sun et al.,
2012). PRRSV induces a polyclonal activation of B-cells accompa-
nied by hypergammaglobulinemia in either PRRSV-infected gno-
tobiotic isolator piglets infected with wild type PRRSV or in fetal
piglets infected with an attenuated virus (Butler et al., 2007, 2008;
Sun et al., 2012). Based on this series of studies, it appears PRRSV
infection results in B-cell receptor engagement on naive B-cells
resulting in a T-independent proliferation of B-cells without
repertoire diversiﬁcation (Butler et al., 2007). One consequence
of this activation may be deregulated cytokine production (e.g.,
excessive IL-10 production by B-cells). Another possible conse-
quence of polyclonal activation of B-cells is that it might even-
tually lead to a functional “hole” in the repertoire of B cells
remaining for recruitment into protective host responses against
a range of pathogens. This hypothesis was ﬁrst proposed regarding
HIV-1 gp 120 being a purported B-cell superantigen and thought
to contribute to immune dysregulation in HIV patients with
overwhelming bacterial sepsis (Muller et al., 1993). In our previous
and current studies with HP-PRRSV strains we noted an increased
incidence of secondary bacterial infections in rJXwn06-infected pigs.
Whether polyclonal activation of B-cells truly creates a hole in the
available antibody repertoire of PRRSV infection remains to be proven.
Clearly the pig′s immune response to PRRSV infection is inadequate to
promptly limit viral replication and prevent disease; identifying how
PRRSV evades an effective immune response will provide clues for
improving vaccines needed to eliminate this virus from swine herds.
Disclaimer
Mention of trade names or commercial products in this article
is solely for the purpose of providing speciﬁc information and does
not imply recommendation or endorsement by the U.S. Depart-
ment of Agriculture.
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Materials and methods
Cultured cell line and viral strains
MARC-145 cells were cultured in minimum essential medium
(EMEM, SAFC 56416C) with 10% fetal bovine serum at 37 1C, 5%
CO2. A cloned full-length cDNA of a 2007 HP-PRRSV isolate from
the Socialist Republic of Vietnam (Metwally et al., 2010) (pSRV07)
was prepared as described below, used to rescue virus (rSRV07) in
transfected MARC-145 cells, passed 2 times and used for this
study. Passage 6 of wild-type (wt) PRRSV strain VR-2332 (GenBank
U87392) (Collins et al., 1992) and HP-PRRSV strain rJXwn06 at
passage 3 (Zhou et al., 2009) were also used. A sham inoculumwas
prepared from virus-free MARC-145 cells. The quantity of each
viral strain was determined using the 50% tissue culture infectious
dose (TCID50/ml) method of Reed and Muench (1938). Passage 3 of
strain MN184 (Han et al., 2006) was used to purify viral RNA for
viral kinetics and northern blot analysis.
SRV infectious clone generation and rescue of virus
Viral RNAwas puriﬁed from rSRV07 infected MARC-145 cells by
the Animal and Plant Health Inspection Service (APHIS) of the
USDA using the QIAamp DNA Blood Maxi Kit and transferred to the
Agricultural Research Service through an APHIS Veterinary Biolo-
gics Permit. RT-PCR was completed using the SuperScripts III
One-Step RT-PCR System with Platinums Taq DNA Polymerase
(Life Technologies 12574-030) with the primers listed in Table 3 to
generate at least three clones for each of the ﬁve segments of the
rSRV07 HP-PRRSV genome. The consensus sequence of three or
more clones was used to build the nucleotide sequence of the
rSRV07 genome (GenBank ID rJX512910). All segments were
initially cloned into the pGEM-T vector. Segment 1 contained an
engineered FseI site followed by an SP6 promoter, a transcription
start guanosine residue followed by PRRSV nucleotides 1–3557,
including the restriction enzyme site XhoI at residue 3401. Seg-
ment 2 spanned bases 2508–5096 and harbors the XhoI site near
the 5′end and a PstI site at residue 4915. Segment 3 included
residues 4800–7676, and incorporated the PstI site at residue 4915
and a unique NheI site at nucleotide 7608. Segment 4 covered
rSRV07 bases 7514–11948 and included the unique NheI site close
to the 5′end and a sole AscI site at residue 11884. Residues 12237–
15320 plus a 30 base polyA tail and an engineered PacI site were
included in Segment 5. To construct the entire genomic rSRV07
cDNA, cloned Segments 1–3 were ﬁrst assembled into one clone in
the following manner: Segment 1 was ﬁrst cut with NdeI in the
multiple cloning site of pGEM-T, blunt-ended, and then cut with
XhoI; Segment 2 was digested with XhoI and PstI at SRV nucleo-
tides 3401 and 4915, respectively; and Segment 3 was digested
with NotI in the multiple cloning site of pGEM-T, blunt-ended,
then released with digestion by PstI at rSRV07 base 4915. A three-
way ligation of these segments yielded the intermediate clone
containing approximately one half of the genome (pT1-3). pT1-3
was then digested with FseI and NheI, cloned Segment 4 was cut
with NheI and AscI, cloned Segment 5 cut with AscI and PacI, and
pOK12HDV-PacI (EF486278) linearized with FseI and PacI were
combined in a four way ligation. The full-length cDNA (pSRV07)
was ampliﬁed, a portion was digested with PacI, transcribed using
mMESSAGE mMACHINEs SP6 Kit (Life Technologies AM1340), and
40ng of the transcript was transfected into each of two wells of a
6 well plate of MARC-145 cells using the reagent DMRIE-C (Life
Technologies 10459-014), as described previously (Han et al.,
2007; Wang et al., 2008). Cytopathic effect became visible in
2 days, and virus was harvested on day 5. The rSRV07 viral stock
was then ampliﬁed by two additional passages on MARC-145 cells.
Viral growth and plaque assays
Growth curve analysis was completed as previously described
(Han et al., 2007). PRRSV strains rJXwn06 at passage 3, rSRV07 at
passage 3 and VR-2332 at passage 7 were individually inoculated at
a multiplicity of infection (m.o.i.) of 0.01 onto MARC-145 mono-
layers in T-25 ﬂasks. After gentle rotation of the ﬂasks for 1 h at
room temperature, the monolayers were washed three times with
EMEM without FBS. After washing, 7 ml EMEM with FBS was
added and the ﬂasks were then incubated for 5 days at 37 1C in
5% CO2. Culture supernatant (500 ml) was collected at 12, 24, 36, 60,
72, 96 and 108 h post infection (hpi) and titrated in duplicate
by viral plaque assay. Diluted virus was added to duplicate wells of a
6-well-plate that contained 90% conﬂuent MARC-145 cell mono-
layers, followed by incubation at room temperature for 1 h with
periodic redistribution of the inoculum. An equal mixture (5 ml
total) of 2 EMEM and 2% SeaPlaques LE agarose (FMC BioPro-
ducts) pre-warmed at 60 1C was added to each well and left at room
temperature for 15 min to solidify the overlay. The cells were then
incubated at 37 1C in 5% CO2 for 96 h. Plaques were stained with
crystal violet and the results were recorded as the number of plaque
forming units (PFU) per ml of inoculum. The morphology of
representative plaques was also documented.
Northern blot analysis
rSRV07, rJXwn06, MN184 and VR-2332 were inoculated in
MARC-145 cells at a m.o.i. of 0.01 and two days after infection
total intracellular RNA was extracted using the Qiagen RNAeasy
mini kit (Qiagen Inc, Valencia, California, USA). Extracted RNA
(10 μg/sample) was denatured at 50 1C for 1 h in 50% dimethylsulf-
oxide (DMSO), 1 M deionized glyoxal, 0.53-(N-morpholino)
propanesulfonic acid (MOPS) buffer and equivalent RNAse-free
water for a ﬁnal volume of 30 ml. Denatured RNA was subjected to
electrophoresis on a 1% glyoxal denaturing gel in 1MOPS buffer
at 4 V per cm. After electrophoresis, the RNA was transferred onto
a 0.45 μm SuPerCharge nylon transfer membrane using the Turbo-
Blotter™ system (Whatman International, Ltd., Piscataway, New
Jersey, USA) for 2 h according to the manufacturer′s instructions
and crosslinked to the membrane with ultraviolet light. The
membrane was hybridized at 40 1C for 12 h with a digoxin-
labeled oligomer (Roche-Applied Science, Indianapolis, Indiana,
USA) complementary to PRRSV 5′ Leader sequence (5′-GTT AAA
GGG GTG GAG AGA CCG TAA AGC AGT GCA ACT CCG G-3′)
according to the manufacturers’ instructions. Post-hybridization,
chemiluminescent detection was conducted using the DIG Nucleic
Acid Detection Kit (Roche-Applied Science) according to the
manufacturers’ instructions. Post-detection, membranes were
exposed to X-ray ﬁlm (Kodak™ BioMax Light Film) for approxi-
mately 10–15 min to visualize the viral RNA.
Animal study design
Animal studies were conducted under the approval of the
Animal Care and Use Committee of the National Animal Disease
Center (NADC). Weaned pigs (n¼77) from a PRRSV-free herd were
delivered at 3-weeks-of age. Each animal received an intramus-
cular injection of ceftiofur crystalline free acid per label dose
(Pﬁzer Animal Health, New York, NY), was identiﬁed by ear tag in a
random fashion and 25–26 animals were housed per isolation
room for one week of acclimation. They were then divided into
7 equal treatment groups and received an intranasal challenge on
0 days post challenge (dpc) with 2 ml of either sham inoculum, or
low (2103 TCID50) or high (2106 CCID50) dose of each
challenge virus (Table 2a). Sham- and VR-2332-challenged pigs
were housed in Animal Biosafety Level (ABSL) 2 isolation rooms
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and rSRV07- and rJXwn06-challenged pigs were housed in ABSL3
isolation rooms for the duration of the study. Pigs were weighed
on 1, 7, and 13 dpc. Blood was collected on 4, 4, 7, 11, and
13 dpc to harvest serum that was stored at 80 1C until testing.
Rectal body temperature was recorded daily from 0 to 13 dpc. At
13 dpc remaining pigs were humanely euthanized for necropsy at
which time the lungs were examined for macroscopic lesions and
bronchoalveolar lavage ﬂuid (BALF) was collected as previously
described (Guo et al., 2013). Swabs of brain surface, pericardial
ﬂuid, and BALF were collected and tested for bacteria as previously
described Sections of lung were immersed in formalin for pro-
cessed in a routing fashion for histology and immunohistochem-
istry (Guo et al., 2013)
Virus and antibody assays
All serum and BALF samples were tested on MARC-145 cells for
virus isolation (VI) (Faaberg et al., 2010). Positive VI samples were
then titered by serial dilution to determine the quantity of virus
present to produce a cytopathic effect of 50% (TCID50). Serum
samples were also tested on study days 4, 4, 7, 11 and 13 for
antibody response with the PRRS 3XR enzyme-linked immuno-
sorbent assay (ELISA; IDEXX Laboratories, Maine, USA). A sample
was considered positive for PRRSV antibodies to if the sample-to-
positive (S/P) ratio was equal to or greater than 0.4.
Bacterial assays
Bacterial culture and bacterial identiﬁcation by 16S rRNA-
speciﬁc PCR and DNA sequencing were performed as described
(Guo et al., 2013).
Cytokine assay
Cytokine (TNF-α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70 and
IFN-γ protein levels (pg/ml) were measured in serum, BALF and
TBLN as described previously using a SearchLight (Aushon BioSys-
tems, Woburn, MA, USA) customized multiplex immunoassay (M-
ELISA) following the manufacturer′s protocol (Guo et al., 2013).
Statistical analysis
Quantitative virus copy numbers and serum cytokine levels
were analyzed using a mixed linear model for repeated measures
(Proc Mixed, SAS 9.2 for Windows, SAS Institute, Cary, NC, USA).
Linear combinations of the least squares means estimates for each
variable were used in a priori contrasts after testing for either a
signiﬁcant (Po0.05) effect of PRRSV challenge strain (VR-2332,
rJXwn06, rSRV07) or sham inoculated controls. Comparisons were
made between groups at each time-point using a 5% level of
signiﬁcance (Po0.05) to assess statistical differences. Log10
transformed virus copy numbers and cytokine levels in BALF and
TBLN homogenates were analyzed by analysis of variance using a
general linear model for unbalanced data (Proc GLM, SAS 9.2 for
Windows, SAS Institute, Cary, NC, USA). A 5% level of signiﬁcance
(Po0.05) was used to assess statistical differences. Geometric
mean back transformations were made for ﬁnal data presentation
in ﬁgures and tables. An analysis of variance on virus copy
numbers in bronchoalveolar lavage ﬂuids collected at necropsy
was done using a general linear model with SAS 9.2 for Windows
(SAS Institute, Cary, NC, USA). Changes in body weight at 7 and
13 dpc were normalized for each pig using 0 dpc weight as value
of 1.0.
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